Strides Arcolab Ltd. said its wholly-owned subsidiary Agila Specialties Pvt. Ltd. had received ANDA approval for Zoledronic Acid Injection 4mg(base)/5mL, packaged in single dose vials.
As per IMS data, the US market for Zoledronic Acid 4mL is around $250 million.
The company said the product would be launched shortly.
Zoledronic Acid is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones.
At the BSE, strides Arcolab shares are currently trading at Rs.900.10, up 2.53 percent from the previous close.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.